NZ500216A - Beta-amyloid peptide-binding proteins and pharmaceutical use - Google Patents

Beta-amyloid peptide-binding proteins and pharmaceutical use

Info

Publication number
NZ500216A
NZ500216A NZ500216A NZ50021698A NZ500216A NZ 500216 A NZ500216 A NZ 500216A NZ 500216 A NZ500216 A NZ 500216A NZ 50021698 A NZ50021698 A NZ 50021698A NZ 500216 A NZ500216 A NZ 500216A
Authority
NZ
New Zealand
Prior art keywords
amyloid peptide
beta
binding proteins
pharmaceutical use
proteins
Prior art date
Application number
NZ500216A
Inventor
Stephen Glen Walker
Bradley A Ozenberger
Eileen Marie Kajkowski
Jack Steven Jacobsen
Jonathan A Bard
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NZ500216A publication Critical patent/NZ500216A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Proteins which bind human beta-amyloid peptide, and polynucleotides that encode these proteins are provided. The polynucleotides and polypeptides may be used in diagnostic, therapeutic, and screening methods for the aberrant expression of human beta-amyloid peptide.
NZ500216A 1997-04-16 1998-04-14 Beta-amyloid peptide-binding proteins and pharmaceutical use NZ500216A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6458397P 1997-04-16 1997-04-16
PCT/US1998/007462 WO1998046636A2 (en) 1997-04-16 1998-04-14 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME

Publications (1)

Publication Number Publication Date
NZ500216A true NZ500216A (en) 2001-06-29

Family

ID=22056941

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ500216A NZ500216A (en) 1997-04-16 1998-04-14 Beta-amyloid peptide-binding proteins and pharmaceutical use

Country Status (18)

Country Link
EP (1) EP0975753A2 (en)
JP (3) JP2001523093A (en)
KR (1) KR20010006393A (en)
CN (2) CN1690203A (en)
AU (1) AU740445B2 (en)
BR (1) BR9808562A (en)
CA (1) CA2286484A1 (en)
EA (1) EA004256B1 (en)
EE (1) EE9900482A (en)
GE (1) GEP20043386B (en)
HU (1) HUP0003116A3 (en)
ID (1) ID24914A (en)
IL (3) IL132236A0 (en)
NO (1) NO995062L (en)
NZ (1) NZ500216A (en)
SK (1) SK143299A3 (en)
UA (1) UA72875C2 (en)
WO (1) WO1998046636A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787319B2 (en) 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
CA2346008A1 (en) * 1998-10-13 2000-04-20 American Home Products Corporation G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same
US6455082B1 (en) * 1999-04-26 2002-09-24 Nestec S.A. Shelf-stable calcium fortified milk and dairy products
WO2001029225A1 (en) * 1999-10-21 2001-04-26 Panorama Research, Inc. A general method for optimizing the expression of heterologous proteins
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US7807171B2 (en) 2003-07-25 2010-10-05 Ac Immune Sa Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
WO2012020124A1 (en) 2010-08-12 2012-02-16 Ac Immune S.A. Vaccine engineering
CN103189050B (en) 2010-10-26 2017-09-29 Ac免疫有限公司 The construct based on liposome comprising the peptide modified by hydrophobic part
CN102060912B (en) * 2010-11-22 2012-11-14 清华大学 Amyloid protein oligomer conformation type epitope polypeptide and application thereof
CN111320678B (en) * 2020-03-09 2023-06-09 安亭生物有限责任公司 Antibacterial peptide mutant and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0332640A1 (en) * 1986-11-17 1989-09-20 California Biotechnology, Inc. Recombinant alzheimer's amyloid protein
IL115743A0 (en) * 1994-10-28 1996-01-19 American Nat Red Cross A mammal with cells containing a transgene and its production
US5786180A (en) * 1995-02-14 1998-07-28 Bayer Corporation Monoclonal antibody 369.2B specific for β A4 peptide

Also Published As

Publication number Publication date
SK143299A3 (en) 2000-09-12
CN1268973A (en) 2000-10-04
AU740445B2 (en) 2001-11-01
WO1998046636A2 (en) 1998-10-22
JP2001523093A (en) 2001-11-20
IL132236A0 (en) 2001-03-19
GEP20043386B (en) 2004-02-10
NO995062L (en) 1999-12-14
KR20010006393A (en) 2001-01-26
HUP0003116A2 (en) 2001-01-29
IL132236A (en) 2007-03-08
JP2008253275A (en) 2008-10-23
EP0975753A2 (en) 2000-02-02
CN1690203A (en) 2005-11-02
ID24914A (en) 2000-08-31
UA72875C2 (en) 2005-05-16
EA199900941A1 (en) 2000-06-26
IL179047A0 (en) 2007-03-08
EA004256B1 (en) 2004-02-26
CA2286484A1 (en) 1998-10-22
HUP0003116A3 (en) 2003-03-28
NO995062D0 (en) 1999-10-15
EE9900482A (en) 2000-06-15
WO1998046636A3 (en) 1999-01-28
BR9808562A (en) 2000-05-23
CN1196785C (en) 2005-04-13
JP2008104465A (en) 2008-05-08
AU7115698A (en) 1998-11-11

Similar Documents

Publication Publication Date Title
DE69841038D1 (en)
AU5671594A (en) Human tissue factor related dna segments, polypeptides and antibodies
HK1019856A1 (en) Therapeutic uses of bpi protein products for human meningococcemia
HK1096974A1 (en) Antibody against human parathormone related peptides
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
AU2001232833A1 (en) Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
BR9709900A (en) Protein binding proteins of prions and their uses.
AU5586500A (en) Human sel-10 polypeptides and polynucleotides that encode them
WO1999035266A3 (en) Human urotensin ii
EP0885959A3 (en) Human Wnt-5b protein
WO2001012806A3 (en) Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof
GB9811221D0 (en) Bacterial-pheromones and uses therefor
WO2001068869A3 (en) Human g-coupled protein receptor kinsaes and polynucleotides encoding the same
ZA966489B (en) New protein human MP52 Arg.
EP0887416A3 (en) Human AFC1
EP0841393A4 (en) HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
DK62690D0 (en) SDK PEPTIDES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC PREPARATION CONTAINING THESE
WO2001094583A3 (en) Human transporter proteins and polynucleotides encoding the same
PT999849E (en) UTILIZATION OF LBP IN TREATMENT OF SEPTICEMIA
WO2002018555A3 (en) Human kinase proteins and polynucleotides encoding the same
AU2076701A (en) Novel human transporter protein and polynucleotides encoding the same
PL344349A1 (en) Human protein c polypeptide
EP0792159A4 (en) Human calcium sensor protein, fragments thereof and dna encoding same

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)